IL1B and ischemia: In addition, we have recently demonstrated that the anti-IL-1β mAb attenuates short-term histopathological I/R-related tissue injury, reduces ischemia-related increases in apoptosis, and reduces I/R-related increases in caspase-3 activity in the fetal brain [94].